LU80596A1 - Amides subsittues de l- et dl-phenylglycine,leur procede de production et compostition pharmaceutique les contenant - Google Patents

Amides subsittues de l- et dl-phenylglycine,leur procede de production et compostition pharmaceutique les contenant Download PDF

Info

Publication number
LU80596A1
LU80596A1 LU80596A LU80596A LU80596A1 LU 80596 A1 LU80596 A1 LU 80596A1 LU 80596 A LU80596 A LU 80596A LU 80596 A LU80596 A LU 80596A LU 80596 A1 LU80596 A1 LU 80596A1
Authority
LU
Luxembourg
Prior art keywords
group
formula
compound
amino
solution
Prior art date
Application number
LU80596A
Other languages
English (en)
French (fr)
Inventor
P Cross
J Danilewicz
I Barnish
Original Assignee
Pfizer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Pfizer filed Critical Pfizer
Publication of LU80596A1 publication Critical patent/LU80596A1/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/06—Dipeptides
    • C07K5/06008—Dipeptides with the first amino acid being neutral
    • C07K5/06078—Dipeptides with the first amino acid being neutral and aromatic or cycloaliphatic
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/08—Vasodilators for multiple indications
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biochemistry (AREA)
  • Diabetes (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cardiology (AREA)
  • Molecular Biology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Urology & Nephrology (AREA)
  • Obesity (AREA)
  • Hematology (AREA)
  • Endocrinology (AREA)
  • Emergency Medicine (AREA)
  • Vascular Medicine (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
LU80596A 1977-11-30 1978-11-29 Amides subsittues de l- et dl-phenylglycine,leur procede de production et compostition pharmaceutique les contenant LU80596A1 (fr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB4997577 1977-11-30
GB4997577 1977-11-30

Publications (1)

Publication Number Publication Date
LU80596A1 true LU80596A1 (fr) 1980-06-05

Family

ID=10454182

Family Applications (1)

Application Number Title Priority Date Filing Date
LU80596A LU80596A1 (fr) 1977-11-30 1978-11-29 Amides subsittues de l- et dl-phenylglycine,leur procede de production et compostition pharmaceutique les contenant

Country Status (20)

Country Link
US (1) US4218474A (nl)
JP (1) JPS5484546A (nl)
AR (1) AR219957A1 (nl)
AT (1) AT362770B (nl)
AU (1) AU507028B2 (nl)
BE (1) BE872347A (nl)
CA (1) CA1101846A (nl)
DE (1) DE2851435C2 (nl)
DK (1) DK531178A (nl)
ES (1) ES475514A1 (nl)
FI (1) FI783638A (nl)
FR (1) FR2410644A2 (nl)
IE (1) IE47635B1 (nl)
IL (1) IL56064A (nl)
IT (1) IT1192590B (nl)
LU (1) LU80596A1 (nl)
NL (1) NL7811692A (nl)
PH (1) PH14681A (nl)
PT (1) PT68834A (nl)
SE (1) SE7812268L (nl)

Families Citing this family (21)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS58224427A (ja) * 1982-06-23 1983-12-26 Canon Electronics Inc 複合磁気ヘツド
JPS5921656A (ja) * 1982-07-28 1984-02-03 Takeda Chem Ind Ltd ポリペプチド誘導体
US4563352A (en) * 1982-10-04 1986-01-07 The Salk Institute For Biological Studies Human pancreatic GRF
US4595677A (en) * 1982-12-03 1986-06-17 Ciba-Geigy Corporation Substituted tetrapeptides
JPS59141547A (ja) * 1983-02-01 1984-08-14 Eisai Co Ltd 鎮痛作用を有する新規ペプタイドおよび製法
GB8322414D0 (en) * 1983-08-19 1983-09-21 Szelke M Renin inhibitors
WO1985003870A1 (en) * 1984-03-01 1985-09-12 Vernon Erk A method of treating hypoglycemia in vertebrates
JPS61501568A (ja) * 1984-03-01 1986-07-31 ア−ク，バ−ノン 脊椎動物の抑うつの治療方法
JPS61501564A (ja) * 1984-03-01 1986-07-31 ア−ク，バ−ノン 老人の記憶疾患の治療方法
EP0174978B1 (en) * 1984-03-01 1990-11-07 ERK, Vernon Method of prophylaxis or treatment of atherosclerosis
EP0181342B1 (en) * 1984-03-01 1992-10-28 ERK, Vernon Method of treating hypertension in vertebrates
US4668663A (en) * 1984-03-27 1987-05-26 Merck & Co., Inc. Renin inhibitors containing homophe8
US4661473A (en) * 1984-03-27 1987-04-28 Merck & Co., Inc. Renin inhibitors containing peptide isosteres
US4659693A (en) * 1984-04-30 1987-04-21 Syntex (U.S.A.) Inc. N,N'-dialkyl substituted guanidino amino acyl residue substituted GRF-analog peptides
DE3527356A1 (de) * 1985-07-31 1987-02-05 Degussa Verfahren zur verbesserung der fruchtbarkeit von haustieren
US5252718A (en) * 1986-04-22 1993-10-12 The Salk Institute For Biological Studies Fibroblast growth factor antagonists
AU637316B2 (en) * 1988-01-28 1993-05-27 Eastman Kodak Company Polypeptide compounds having growth hormone releasing activity
NL1010506C2 (nl) * 1998-11-06 2000-05-09 Dsm Nv Werkwijze voor de bereiding van bêta-lactam antibiotica.
KR100389644B1 (ko) * 2001-02-26 2003-06-27 한미약품 주식회사 4-히드록시페닐글리신 무수물 및 이의 제조방법
US7230097B2 (en) * 2003-03-10 2007-06-12 Lupin Ltd. Process for preparation of 7-[α-Amino (4-hydroxyphenyl) acetamido]-3-substituted-3-cephem-4-carboxylic acid
JP1610197S (nl) 2017-09-25 2018-07-30

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2868818A (en) * 1953-12-15 1959-01-13 Merck & Co Inc Alpha methyl phenylalanines
US2833764A (en) * 1954-11-18 1958-05-06 American Cyanamid Co O-methyl-l-tyrosyl amides and their preparation
US3725470A (en) * 1969-05-14 1973-04-03 Hoffmann La Roche Amino acid derivatives
ES400897A1 (es) * 1972-03-18 1975-02-01 Beecham Group Ltd Un procedimiento para la preparacion de alfa-amino-p-hidro-xibencilpenicilina o de un ester de grafito.
DE2510634A1 (de) * 1975-03-12 1976-09-23 Boehringer Mannheim Gmbh L-3-(3,4-dihydroxy-phenyl)-2- methyl-alanin-peptide und verfahren zu deren herstellung
NL7514300A (nl) * 1975-12-09 1977-06-13 Stamicarbon Werkwijze voor de bereiding van optisch actief fenylglycineamide.
US4107440A (en) * 1975-12-15 1978-08-15 Smithkline Corporation Intermediates for preparing substituted phenylglycylcephalosporins
GB1547206A (en) * 1976-09-28 1979-06-06 Pfizer Ltd Pharmaceutical compositions
PH14064A (en) * 1977-05-06 1981-01-26 Pfizer Phenylgycine derivatives,pharmaceutical compositions and method of use

Also Published As

Publication number Publication date
DE2851435A1 (de) 1979-06-13
AU4200878A (en) 1979-06-07
ES475514A1 (es) 1979-04-01
IL56064A (en) 1982-01-31
IE782359L (en) 1979-05-30
IT7830290A0 (it) 1978-11-28
IE47635B1 (en) 1984-05-16
FR2410644B2 (nl) 1982-10-08
AU507028B2 (en) 1980-01-31
AT362770B (de) 1981-06-10
FI783638A (fi) 1979-05-31
JPS5484546A (en) 1979-07-05
IT1192590B (it) 1988-04-20
DE2851435C2 (de) 1982-11-25
JPS5740139B2 (nl) 1982-08-25
CA1101846A (en) 1981-05-26
PH14681A (en) 1981-11-10
IL56064A0 (en) 1979-01-31
BE872347A (fr) 1979-05-28
AR219957A1 (es) 1980-09-30
US4218474A (en) 1980-08-19
ATA850678A (de) 1980-11-15
DK531178A (da) 1979-05-31
PT68834A (en) 1978-12-01
NL7811692A (nl) 1979-06-01
SE7812268L (sv) 1979-05-31
FR2410644A2 (fr) 1979-06-29

Similar Documents

Publication Publication Date Title
LU80596A1 (fr) Amides subsittues de l- et dl-phenylglycine,leur procede de production et compostition pharmaceutique les contenant
EP0679161B1 (fr) Derives de thiazolidine, leur preparation et les medicaments les contenant
EP0162036B1 (fr) (S)-alpha-éthyl-2-oxo-1-pyrrolidineacétamide
LU79761A1 (fr) Procede de preparation de nouveaux composes de phtalazine et de composition pharmaceutique les contenant
CH642618A5 (fr) Phenethanolamines et compositions pharmaceutiques en contenant.
CH639653A5 (fr) Aminothiazoles et composition pharmaceutique les contenant.
CA1213280A (fr) PROCEDE DE PREPARATION DE NOUVEAUX DERIVES DE 4-(1H- INDOL-3-YL) .alpha.-METHYL PIPERIDINE-1-ETHANOL ET DE LEURS SELS
EP0005689B1 (fr) Nouveaux acides lactame-N-acétiques et leurs amides, leurs procédés de préparation et compositions thérapeutiques
EP0888289A1 (en) Anticonvulsant enantiomeric amino acid derivatives
CH641759A5 (fr) Phenethanolamines et composition pharmaceutique antineoplastique les contenant.
CA2101058A1 (fr) Composes a structure guanidique et composition pharmaceutique les contenant
EP0024960B1 (fr) Nouvelles phénoxyamines hétérocycliques substituées, procédé pour leur préparation et leur application comme anesthésiques locaux
FR2493311A1 (fr) Derives 2,6-c-dimethyltyrosine1-(d-amino-acide)2-(acide e-amino-caproique et acide g-aminobutyrique)5 de la methionine-encephaline, utiles notamment comme analgesiques
EP0005658A1 (fr) Nouveaux dérivés de peptides analogues des enképhalines, leur procédé de préparation et leur application thérapeutique
EP0004494B1 (fr) Nouveaux dérivés de 1,3-dihydro 3-(1-(2-(2,3-dihydro 1,4-benzo-dioxin-2-yl)2-hydroxy éthyl)pipéridin-4-yl)2H-indol 2-one, leur procédé de préparation, leur application comme médicaments et les compositions pharmaceutiques les renfermant
EP0262053A2 (fr) Nouveaux dérivés d'amino-acides, leur procédé de préparation et compositions pharmaceutiques les contenant
EP0385848A1 (fr) Nouveaux dérivés benzoxazolinoniques, leurs procédés de préparation et les compositions pharmaceutiques qui les contiennent
CA1053679A (fr) N-(trifluoromethyl-3-phenyl)-1-propyl-2 glycinate de aminoalkyle
CH625214A5 (nl)
FR2548187A1 (fr) Composes d'organo-germanium et leurs utilisations therapeutiques en tant qu'inhibiteurs des enzymes qui degradent les peptides opioides
EP0150139A2 (fr) Dérivés de l'indole éthénylphénol, leurs sels, procédé de préparation, application à titre de médicaments,et compositions les renfermant
BE893553A (fr) Derives de la proline et procede pour les preparer
FR2597865A1 (fr) Nouveaux derives d'un acide benzyl alkyl carboxylique substitue par un radical 4-pyridinyl aminocarbonyle, leur procede de preparation, les nouveaux intermediaires obtenus, leur application a titre de medicaments et les compositions pharmaceutiques les renfermant
CH675998A5 (nl)
EP0022017B1 (fr) Nouveaux dérivés de benzoyl-2 nitro-4 anilides, leur préparation et leur application en tant que médicaments